Why cutting fat release from fat cells helps lower blood sugar after meals
Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 554 / 90
Evidence Score
Participants are randomly assigned to treatment or control groups, minimizing bias. Considered the gold standard for testing whether an intervention causes an effect.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 554 / 90
Evidence Score
Participants are randomly assigned to treatment or control groups, minimizing bias. Considered the gold standard for testing whether an intervention causes an effect.
Publication
Journal
American journal of physiology. Endocrinology and metabolism
Year
2005
Authors
P. Carey, J. Gerrard, G. Cline, C. Dalla Man, P. English, M. Firbank, C. Cobelli, Roy Taylor
Related Content
Claims (6)
After eating, elevated blood glucose levels stimulate the release of insulin, which facilitates the movement of glucose into cells and reduces the breakdown of fat.
In healthy adults, people with less fat in their liver tend to have a greater reduction in blood sugar after taking acipimox, while those with more liver fat show less reduction.
In healthy adults without diabetes, higher levels of fat in the liver are associated with reduced sensitivity to insulin, suggesting liver fat content can signal broader metabolic issues.
When healthy adults are given a drug called acipimox to temporarily block fat breakdown, their blood sugar and insulin levels after eating drop by about 12% and 28%, respectively, but the liver's production of glucose remains unchanged.
When a drug called acipimox lowers free fatty acids in the blood, it does not change how the liver reduces its own glucose production after a meal in healthy people, even though blood sugar and insulin levels drop. This suggests that the liver’s glucose output is not the main reason for improved blood sugar control in this scenario.